The relationship between data-privacy lawmakers and genomics researchers may have gotten off on the wrong foot. Critics of protectionism in the current laws advocate that we abandon the existing paradigm, which was formulated in an entirely different medical research context. Genomic research no longer requires physically risky interventions that directly affect participants’ integrity. But to ...
